Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
Crossref DOI link: https://doi.org/10.2337/dc14-1625
Published Online: 2015-06-18
Published Print: 2015-12-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Giorgino, Francesco
Benroubi, Marian
Sun, Jui-Hung
Zimmermann, Alan G.
Pechtner, Valeria
Funding for this research was provided by:
Eli Lilly and Company
Version of Record valid from 2016-06-01
